Roche gets Swiss approval for skin cancer drug

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG has received Swiss approval for Erivedge, the first medicine for people with advanced forms of basal cell carcinoma, the most common skin cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news